The national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), published in September 2020, provides guidance for clinicians caring for children with PIMS-TS. It includes information on investigations, clinical management and discharge criteria.
Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) - national consensus management pathway
Most children are asymptomatic or exhibit mild symptoms from COVID-19 infection. However, a small number have been identified who develop a significant systemic inflammatory response, which is also known as PIMS-TS or PIMS). In September 2020 a national consensus management pathway was published to provide guidance for clinicians caring for children with PIMS-TS.